WT1 TCR therapy (gene-modified)

WT1-specific T-cell receptor therapy · Cell Medica Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WT1 TCR therapy (gene-modified), covering 2018-10-02 to 2018-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients [Phase 1, Phase 2]